Fig. 32From: Assessment of hepatocellular carcinoma treatment response with LI-RADS: a pictorial reviewAxial T1-weighted MR obtained (a) pretreatment: image in late arterial phase (AP) shows a 5-cm LR-5 observation (arrow). b 1 month post transarterial radioembolization (TARE): image in portal venous phase shows hypoenhancing area. c 1 year post TARE: image in late AP shows expected capsular retraction and perfusional anomalies (asterisk). The treated observation is categorized LR-TR NonviableBack to article page